StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) KPIs and segments

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.98−0.16 (-7.48%)

Close on Nov 16, 2026Market cap $158.75MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BridgeBio Oncology Therapeutics's business

Coming soon

This tab will track the numbers specific to BridgeBio Oncology Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?